ARCHIVES

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

This article is from The Cancer Letter archive.

Vol. 40 No. 01 | January 3, 2014

Download PDF Visit The Full Archive

Related Articles

Conte Withdraws Amendments Adding $40 Million for Flood Promise To Compromise

June 24, 1977

Proteomics Used To Find Predictor Of Response In FAP

April 30, 2004

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

April 20, 2012

New Coalition To Lobby for Prevention

November 24, 1978

IARC Says Evidence Supports Mammography Screening For 50-69, Limited Evidence For 40-49

March 22, 2002

BRMP Workshops Planned; DCT Board Balk At Size of Intramural Budget

November 28, 1980